(VITL) Vital Farms - Overview
Sector: Consumer DefensiveIndustry: Farm Products | Exchange NASDAQ (USA) | Currency USD | Market Cap: 618m | Total Return -56.6% in 12m
Stock: Eggs, Butter, Dairy, Food
Total Rating 41
Risk 88
Buy Signal -1.44
| Risk 5d forecast | |
|---|---|
| Volatility | 50.5% |
| Relative Tail Risk | -0.97% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.44 |
| Alpha | -69.03 |
| Character TTM | |
|---|---|
| Beta | 0.838 |
| Beta Downside | 0.643 |
| Drawdowns 3y | |
|---|---|
| Max DD | 75.18% |
| CAGR/Max DD | -0.07 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
choppy
Description: VITL Vital Farms March 05, 2026
Vital Farms, Inc. (VITL) is a US-based food company specializing in ethical food products. They package and distribute shell eggs, butter, and other related items. The company emphasizes sourcing from family farms, aligning with the growing consumer preference for sustainably and ethically produced food.
Their product portfolio includes shell eggs, butter, hard-boiled eggs, and liquid whole eggs, sold under the Vital Farms brand and other trade names. Distribution channels include third-party distributors, direct sales to retailers, and commercial and non-commercial foodservice operators. This multi-channel approach is common for food companies seeking broad market penetration.
Founded in 2007 and headquartered in Austin, Texas, Vital Farms operates within the Packaged Foods & Meats sub-industry. Further research into the companys financials on ValueRay can provide deeper insights into its market position and performance.
Headlines to watch out for
- Egg and butter demand drives revenue growth
- Input costs for feed and labor impact profitability
- Regulatory changes for animal welfare affect operations
- Retailer relationships are crucial for product distribution
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 66.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.09 > 0.02 and ΔFCF/TA -19.25 > 1.0 |
| NWC/Revenue: 18.56% < 20% (prev 27.63%; Δ -9.07% < -1%) |
| CFO/TA 0.06 > 3% & CFO 33.7m > Net Income 66.3m |
| Net Debt (4.66m) to EBITDA (112.3m): 0.04 < 3 |
| Current Ratio: 2.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.0m) vs 12m ago 0.80% < -2% |
| Gross Margin: 37.62% > 18% (prev 0.38%; Δ 3.72k% > 0.5%) |
| Asset Turnover: 173.0% > 50% (prev 168.7%; Δ 4.25% > 0%) |
| Interest Coverage Ratio: 42.41 > 6 (EBITDA TTM 112.3m / Interest Expense TTM 2.20m) |
Altman Z'' 5.09
| A: 0.27 (Total Current Assets 262.6m - Total Current Liabilities 121.6m) / Total Assets 518.7m |
| B: 0.29 (Retained Earnings 149.4m / Total Assets 518.7m) |
| C: 0.21 (EBIT TTM 93.5m / Avg Total Assets 439.0m) |
| D: 0.89 (Book Value of Equity 149.4m / Total Liabilities 167.5m) |
| Altman-Z'' Score: 5.09 = AAA |
Beneish M -2.69
| DSRI: 1.00 (Receivables 67.8m/54.3m, Revenue 759.4m/606.3m) |
| GMI: 1.01 (GM 37.62% / 37.92%) |
| AQI: 1.15 (AQ_t 0.03 / AQ_t-1 0.03) |
| SGI: 1.25 (Revenue 759.4m / 606.3m) |
| TATA: 0.06 (NI 66.3m - CFO 33.7m) / TA 518.7m) |
| Beneish M-Score: -2.69 (Cap -4..+1) = A |
What is the price of VITL shares?
As of March 28, 2026, the stock is trading at USD 13.14 with a total of 2,287,891 shares traded.
Over the past week, the price has changed by -9.44%, over one month by -37.70%, over three months by -59.58% and over the past year by -56.59%.
Over the past week, the price has changed by -9.44%, over one month by -37.70%, over three months by -59.58% and over the past year by -56.59%.
Is VITL a buy, sell or hold?
Vital Farms has received a consensus analysts rating of 4.80.
Therefore, it is recommended to buy VITL.
- StrongBuy: 8
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the VITL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.5 | 177.8% |
| Analysts Target Price | 36.5 | 177.8% |
VITL Fundamental Data Overview March 26, 2026
P/E Trailing = 9.5833
P/E Forward = 208.3333
P/S = 0.814
P/B = 1.76
Revenue TTM = 759.4m USD
EBIT TTM = 93.5m USD
EBITDA TTM = 112.3m USD
Long Term Debt = 53.5m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 10.3m USD (from shortTermDebt, last quarter)
Debt = 53.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.66m USD (from netDebt column, last quarter)
Enterprise Value = 558.3m USD (618.2m + Debt 53.5m - CCE 113.4m)
Interest Coverage Ratio = 42.41 (Ebit TTM 93.5m / Interest Expense TTM 2.20m)
EV/FCF = -11.58x (Enterprise Value 558.3m / FCF TTM -48.2m)
FCF Yield = -8.64% (FCF TTM -48.2m / Enterprise Value 558.3m)
FCF Margin = -6.35% (FCF TTM -48.2m / Revenue TTM 759.4m)
Net Margin = 8.73% (Net Income TTM 66.3m / Revenue TTM 759.4m)
Gross Margin = 37.62% ((Revenue TTM 759.4m - Cost of Revenue TTM 473.8m) / Revenue TTM)
Gross Margin QoQ = 35.79% (prev 37.68%)
Tobins Q-Ratio = 1.08 (Enterprise Value 558.3m / Total Assets 518.7m)
Interest Expense / Debt = 2.88% (Interest Expense 1.54m / Debt 53.5m)
Taxrate = 27.20% (6.10m / 22.4m)
NOPAT = 68.0m (EBIT 93.5m * (1 - 27.20%))
Current Ratio = 2.16 (Total Current Assets 262.6m / Total Current Liabilities 121.6m)
Debt / Equity = 0.15 (Debt 53.5m / totalStockholderEquity, last quarter 351.3m)
Debt / EBITDA = 0.04 (Net Debt 4.66m / EBITDA 112.3m)
Debt / FCF = -0.10 (negative FCF - burning cash) (Net Debt 4.66m / FCF TTM -48.2m)
Total Stockholder Equity = 320.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.10% (Net Income 66.3m / Total Assets 518.7m)
RoE = 20.69% (Net Income TTM 66.3m / Total Stockholder Equity 320.3m)
RoCE = 25.01% (EBIT 93.5m / Capital Employed (Equity 320.3m + L.T.Debt 53.5m))
RoIC = 21.25% (NOPAT 68.0m / Invested Capital 320.3m)
WACC = 8.39% (E(618.2m)/V(671.7m) * Re(8.93%) + D(53.5m)/V(671.7m) * Rd(2.88%) * (1-Tc(0.27)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.03%
[DCF] Fair Price = unknown (Cash Flow -48.2m)
EPS Correlation: 83.53 | EPS CAGR: 114.5% | SUE: -0.68 | # QB: 0
Revenue Correlation: 97.45 | Revenue CAGR: 31.23% | SUE: 0.10 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.32 | Chg7d=-0.005 | Chg30d=-0.112 | Revisions Net=-6 | Analysts=9
EPS current Year (2026-12-31): EPS=1.32 | Chg7d=-0.007 | Chg30d=-0.381 | Revisions Net=-9 | Growth EPS=-8.0% | Growth Revenue=+19.2%
EPS next Year (2027-12-31): EPS=1.65 | Chg7d=+0.002 | Chg30d=-0.518 | Revisions Net=-3 | Growth EPS=+24.2% | Growth Revenue=+18.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -1.5% (Discount Rate 8.9% - Earnings Yield 10.4%)
[Growth] Growth Spread = +20.5% (Analyst 19.0% - Implied -1.5%)
P/E Forward = 208.3333
P/S = 0.814
P/B = 1.76
Revenue TTM = 759.4m USD
EBIT TTM = 93.5m USD
EBITDA TTM = 112.3m USD
Long Term Debt = 53.5m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 10.3m USD (from shortTermDebt, last quarter)
Debt = 53.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.66m USD (from netDebt column, last quarter)
Enterprise Value = 558.3m USD (618.2m + Debt 53.5m - CCE 113.4m)
Interest Coverage Ratio = 42.41 (Ebit TTM 93.5m / Interest Expense TTM 2.20m)
EV/FCF = -11.58x (Enterprise Value 558.3m / FCF TTM -48.2m)
FCF Yield = -8.64% (FCF TTM -48.2m / Enterprise Value 558.3m)
FCF Margin = -6.35% (FCF TTM -48.2m / Revenue TTM 759.4m)
Net Margin = 8.73% (Net Income TTM 66.3m / Revenue TTM 759.4m)
Gross Margin = 37.62% ((Revenue TTM 759.4m - Cost of Revenue TTM 473.8m) / Revenue TTM)
Gross Margin QoQ = 35.79% (prev 37.68%)
Tobins Q-Ratio = 1.08 (Enterprise Value 558.3m / Total Assets 518.7m)
Interest Expense / Debt = 2.88% (Interest Expense 1.54m / Debt 53.5m)
Taxrate = 27.20% (6.10m / 22.4m)
NOPAT = 68.0m (EBIT 93.5m * (1 - 27.20%))
Current Ratio = 2.16 (Total Current Assets 262.6m / Total Current Liabilities 121.6m)
Debt / Equity = 0.15 (Debt 53.5m / totalStockholderEquity, last quarter 351.3m)
Debt / EBITDA = 0.04 (Net Debt 4.66m / EBITDA 112.3m)
Debt / FCF = -0.10 (negative FCF - burning cash) (Net Debt 4.66m / FCF TTM -48.2m)
Total Stockholder Equity = 320.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.10% (Net Income 66.3m / Total Assets 518.7m)
RoE = 20.69% (Net Income TTM 66.3m / Total Stockholder Equity 320.3m)
RoCE = 25.01% (EBIT 93.5m / Capital Employed (Equity 320.3m + L.T.Debt 53.5m))
RoIC = 21.25% (NOPAT 68.0m / Invested Capital 320.3m)
WACC = 8.39% (E(618.2m)/V(671.7m) * Re(8.93%) + D(53.5m)/V(671.7m) * Rd(2.88%) * (1-Tc(0.27)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.03%
[DCF] Fair Price = unknown (Cash Flow -48.2m)
EPS Correlation: 83.53 | EPS CAGR: 114.5% | SUE: -0.68 | # QB: 0
Revenue Correlation: 97.45 | Revenue CAGR: 31.23% | SUE: 0.10 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.32 | Chg7d=-0.005 | Chg30d=-0.112 | Revisions Net=-6 | Analysts=9
EPS current Year (2026-12-31): EPS=1.32 | Chg7d=-0.007 | Chg30d=-0.381 | Revisions Net=-9 | Growth EPS=-8.0% | Growth Revenue=+19.2%
EPS next Year (2027-12-31): EPS=1.65 | Chg7d=+0.002 | Chg30d=-0.518 | Revisions Net=-3 | Growth EPS=+24.2% | Growth Revenue=+18.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -1.5% (Discount Rate 8.9% - Earnings Yield 10.4%)
[Growth] Growth Spread = +20.5% (Analyst 19.0% - Implied -1.5%)